News shared by:

336 Articles
07 Oct 2019
Gilead’s Descovy approved in HIV prophylaxis in the US

The FDA has approved Gilead’s combination drug Descovy for HIV prophylaxis in the US, offering a way of cutting the risk of sexually acquired infection with an improved safety profile...

07 Oct 2019
Eli Lilly announced results CYRAMZA

Eli Lilly and Company today announced that results from the global Phase 3 RELAY trial of CYRAMZA® (ramucirumab) in previously untreated patients with metastatic EGFR-mutated non-small...

05 Oct 2019
FDA Approved Self-Administration of AstraZeneca the Fasenra Pen

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved the self-administration of Fasenra (benralizumab) in a pre-filled, single-use auto-injector...

05 Oct 2019
A new initiative aims to revitalise drug discovery for mental health conditions

The Psychiatry Consortium’s first ‘challenge call’ encourages applicants from academic and other research organisations worldwide to apply for funding. The consortium aims to...

03 Oct 2019
Biocon and Mylan Launched Semglee

Biocon Ltd and Mylan N.V. today announced the launch of Semglee® (insulin glargine solution for injection 100 IU/mL in a 3mL pre-filled pen), the first insulin glargine...

03 Oct 2019
Eli Lilly Announces Voluntary Delisting from Euronext Paris

Eli Lilly and Company (NYSE: LLY) announced today that it has requested the delisting of its shares (ISIN US5324571083) ("Lilly Shares") from Euronext Paris due to the very low...

Block ?

If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock

Complain

The user will not know who exactly sent the complaint

Delete Company

The user will not know who exactly sent the complaint

Notifications

You Have 112 readed notifications

CHATS

Select chat category

×